Actively Recruiting
Comparative Effectiveness Trial of Technology-Based Versus Team-Based Supportive Cancer Care Delivery Models for Adults With Cancer
Led by Stanford University · Updated on 2026-04-30
2996
Participants Needed
17
Research Sites
4 weeks
Total Duration
On this page
Sponsors
S
Stanford University
Lead Sponsor
P
Patient-Centered Outcomes Research Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are comparing two approaches to supportive cancer care for adults with cancer. This trial aims to evaluate which method better improves health-related quality of life, patient activation, satisfaction with care and decision-making, documentation of goals and symptoms, and reduces acute care use such as emergency visits and hospitalizations. The study focuses on patients with newly diagnosed or recurrent solid tumor cancers. Participants are assigned to one of two groups. One group receives educational materials about advance care planning and symptom management through technology messages weekly for the first 4 months and biweekly for months 5 through 12. The other group works with a lay health worker who discusses the same materials in person or by phone on the same schedule over 12 months. Both groups receive ongoing supportive care tailored to improve their cancer experience. Participants complete a baseline interview at enrollment by phone, followed by surveys at 3, 6, and 12 months. Researchers track changes in quality of life using the FACT-G questionnaire, patient activation, satisfaction with care and decision-making, use of palliative and hospice care, emergency visits, hospitalizations, and documentation of care goals and symptoms. The study runs through February 2028, allowing long-term monitoring of supportive care outcomes.
CONDITIONS
Brief Title
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Newly diagnosed patients with solid tumor cancer diagnosis or recurrence of the disease
- Ability to understand and willingness to provide verbal consent
- Ability to speak English, Spanish, Chinese, or Vietnamese
You will not qualify if you...
- Inability to consent to the study
- Plans to change oncologist within 12 months
- Employment by the practice site
- Anticipation of moving from the area within 12 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or phone) during initial consent contact
Duration - 12 months
Participants receive supportive cancer care either through technology-based educational materials or through one-on-one discussions with a lay health worker to assist with advance care planning and symptom management.
Weekly visits during months 1-4 and every other week during months 5-12
Duration - 12 months
Participants complete surveys and assessments to measure quality of life, patient activation, satisfaction with care and decision-making, and documentation of care goals and symptoms.
Surveys at 3, 6, and 12 months post enrollment
Trial Site Locations
Total: 17 locations
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294
Actively Recruiting
2
University of South Alabama
Mobile, Alabama, United States, 36688
Actively Recruiting
3
Beckman Research Institute of City of Hope
Duarte, California, United States, 91010
Actively Recruiting
4
VA Medical Center, Fresno
Fresno, California, United States, 93703
Actively Recruiting
5
Santa Clara Valley Medical Center
Fruitdale, California, United States, 95128
Actively Recruiting
6
St Jude Heritage Medical Group
Fullerton, California, United States, 92835
Actively Recruiting
7
Oncology Institute for Hope and Innovation
Los Angeles, California, United States, 90017
Actively Recruiting
8
Sacramento VA Medical Center - VA Northern California Health Care System
Mather, California, United States, 95655
Active, Not Recruiting
9
Pacific Cancer Care
Monterey, California, United States, 93940
Active, Not Recruiting
10
VA Palo Alto
Palo Alto, California, United States, 94305
Active, Not Recruiting
11
Zuckerberg San Francisco General
San Francisco, California, United States, 94110
Actively Recruiting
12
Kaiser Foundation Research Institute
San Francisco, California, United States, 94115
Actively Recruiting
13
University of San Francisco
San Francisco, California, United States, 94117
Actively Recruiting
14
San Francisco VA Medical Center
San Francisco, California, United States, 94121
Active, Not Recruiting
15
Spark M. Matsunaga VA Medical Center
Honolulu, Hawaii, United States, 96819
Actively Recruiting
16
North Las Vegas VA Medical Center
Las Vegas, Nevada, United States, 89086
Active, Not Recruiting
17
George E. Wahlen Department of Veterans Affairs Medical Center
Salt Lake City, Utah, United States, 84148
Actively Recruiting
Research Team
M
Manali I Patel, MD MPH MS
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here